Atea Pharmaceuticals
AVIR
AVIR
80 hedge funds and large institutions have $3.04B invested in Atea Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 24 increasing their positions, 25 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 9 → 9 (0)
0.57% less ownership
Funds ownership: 60.41% → 59.84% (-0.57%)
4% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 25
Holders
80
Holding in Top 10
9
Calls
$2.04M
Puts
$1.12M
Top Buyers
| 1 | +$266M | |
| 2 | +$4.79M | |
| 3 | +$4.35M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$3.82M |
| 5 |
E
Ergoteles
New York
|
+$3.11M |
Top Sellers
| 1 | -$110M | |
| 2 | -$66.3M | |
| 3 | -$15.4M | |
| 4 |
BlackRock
New York
|
-$14.8M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$10.1M |